Pregnancy, Babies, Parenting News & Tips

Cocerns raised over potency of FDA-approved Zohydro pain pill

By Jenna Iacurci / Feb 26, 2014 04:26 PM EST

Tags : addiction, Zohydro, pain, pill, medication, overdose, abuse

  • Concern over addictive Zohydro pain pill
  • (Photo : Flickr.Thirteen of Clubs) Health care, consumer and addiction treatment groups are concerned about the newly FDA-approved Zohydro pain pill.

Health care, consumer and addiction treatment groups are concerned about the newly FDA-approved Zohydro pain pill.

This coalition is urging the Food and Drug Administration to retract its approval of the prescription painkiller, classified under opioid analgesics, for fear of its potency and potential for abuse.

Like Us on Facebook

The medication was approved last fall to treat chronic pain and will be available to patients in March; however, that hasn't stopped concerned individuals from writing letters to the FDA asking the agency to take it off the market.

"In the midst of a severe drug epidemic fueled by overprescribing of opioids, the very last thing the country needs is a new, dangerous, high-dose opioid," the groups wrote in a letter to FDA Commissioner Dr. Margaret Hamburg, reports CNN.

According to the Centers for Disease Control and Prevention, prescription opioid deaths have quadrupled since 1999 and these groups are worried that, based on its potency, Zohydro could contribute to this climb.

"You're talking about a drug that's somewhere in the neighborhood of five times more potent than what we're dealing with now," said Dr. Stephen Anderson, a Washington emergency room physician who is not a part of the current petition. "I'm five times more concerned, solely based on potency."

The maker of the drug, Zogenix, believes that Zohydro's benefit outweighs its health concerns.

"We do not expect the introduction of Zohydro ER (extended release) to increase the overall use of opioids," said Dr. Brad Galer, executive vice president and chief medical officer at Zogenix. "In fact, prescription data from the last five years shows that total use of ER opioids is constant and independent of new entrants to the market."

Galer added that the company would ensure only appropriate patients with chronic pain would receive the painkiller - those with low back pain, fibromyalgia, arthritis or other chronic conditions - if it's used like other opioids.

Meanwhile, the FDA has switched the drug to Schedule II (still pending approval by the Drug Enforcement Administration), meaning stricter dispensing and prescribing rules.

© 2014 ParentHerald.com All rights reserved. Do not reproduce without permission.

Let nature play a role in climate adaptation, experts urge: TRFN

Delegates take notes during a plenary session of the U.N. Climate Change Conference COP 20 in Lima December 13, 2014.

Read More »

U.N. talks agree building blocks for new-style climate deal in 2015

Delegates listen as COP 20 President and Peru's Environment Minister Manuel Pulgar Vidal makes an announcement during a plenary session of the U.N. Climate Change Conference COP 20 in Lima December 12, 2014.

Read More »

Paris climate summit faces tougher job after modest Lima deal

Delegates talk during a break at a plenary session of the U.N. Climate Change Conference COP 20 in Lima December 12, 2014.

Read More »

Fractures are major cause of older women’s hospitalizations

Fractures are major cause of older women’s hospitalizations

Read More »

Cost of not supporting breastfeeding may be millions

Cost of not supporting breastfeeding may be millions

Read More »

Taking HIV prevention pill may not encourage risky sex: U.S. study

Taking HIV prevention pill may not encourage risky sex: U.S. study

Read More »

Sony hacking highlights challenge to CEO Hirai's 'One Sony' vision

An entrance gate to Sony Pictures Entertainment at the Sony Pictures lot is pictured in Culver City, California April 14, 2013.

Read More »

Amazon workers strike in Germany as Christmas orders peak

A Verdi union scarf is seen outside the Amazon logistics centre in Graben near Augsburg December 15, 2014.

Read More »

U.S. faces tough questions in Apple e-books antitrust appeal

A general view of an Apple store in the Manhattan borough of New York September 7, 2014.

Read More »

Ebola toll in Guinea, Sierra Leone and Liberia reaches 6,583: WHO

Medical staff working with Medecins sans Frontieres (MSF) prepare to bring food to patients kept in an isolation area at the MSF Ebola treatment centre in Kailahun July 20, 2014.

Read More »

Shock treatment: what's missing from Sierra Leone's Ebola response

World Health Organization (WHO) Assistant Director General Bruce Aylward gestures during a news conference on the WHO response and challenges to control the Ebola outbreak at the United Nations in Geneva December 1, 2014.

Read More »

Top court rejects Arizona appeal over abortion drug law

People wait in line to enter the U.S. Supreme Court in Washington November 10, 2014.

Read More »

Real Time Analytics